type here...

CATEGORIES

Policy and Practice

LATEST

1...151617...32Page 16 of 32

TRENDING

EDITORS CHOICE

Twitter’s Decision to Stand-down on COVID Misinformation Highlights a New Symptom — “Trust Deregulation”

Gil Bashe, Medika Life Editor -
If Twitter and Elon Musk Fail and Fall, Who Will Celebrate? Twitter and COVID misinformation monitoring.

Conceptually, the “Make America Healthy Again Movement” Needs a Nod

Gil Bashe, Medika Life Editor -
The health innovation paradox – breakthrough medications and dedicated providers. We spend more and live fewer years than other nations.

India’s Pivotal Regulatory Shift: A Possible Game-Changer in Expediting Medicines to Millions in Dire Need

Gil Bashe, Medika Life Editor -
“Go to India” May Be a Key Market for Pharma Company Growth and Global Public Health

Business of Health: When Patients Become Secondary to the System

Gil Bashe, Medika Life Editor -
Can the Health System Align Around a Common Goal — Better Health

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories